Login to Your Account

Ark's £27.1M Funding Should Fuel Pipeline's Confirmation

By Nuala Moran

Wednesday, May 3, 2006
LONDON - Ark Therapeutics plc raised £27.1 million (US$49.5 million) in a placing and open offer, reinforcing its cash position and providing the resources to get two gene therapy products to commercialization, along with a third product for treating cancer cachexia. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription